- Village Hotel Changi, Singapore
June 20 to 22, 2025 - +1-571-5561014
diabetes@precisionglobalconferences.com
scientific Sessions
Pharmacogenomics in Diabetes:
Description: The field of pharmacogenomics in diabetes is concerned with how genetic variations affect responses to diabetes drugs. People will be better managed through personalization based on genetic profiling, reducing the risk of adverse effects and optimizing drug efficacy. Such genetic factors can influence the metabolism of drugs like insulin, metformin, and GLP-1 agonists, resulting in more tailored therapy. The pharmacogenomics research has great potential to improve diabetes care by indicating the patients who will receive maximum benefit from specific medication. Incorporation of pharmacogenomic testing into clinical practice could change the way diabetes is managed in clinics. Experts will discuss how the recent advances in pharmacogenomics have led to personalized approaches to diabetes treatment at the Diabetes and Endocrinology World Conference (DEWC).
Related Sessions
Don't miss our future updates!